Beyond 12 Hours Reperfusion Alternative Evaluation Trial - BRAVE-2

Description:

The goal of the trial was to evaluate treatment with percutaneous coronary intervention (PCI) among patients with ST elevation myocardial infarction (MI) presenting longer than 12 hours after symptom onset without persistent chest pain.